These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34986486)

  • 21. Association between Aspartate Aminotransferase-to-Platelet Ratio Index and Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis: A Meta-Analysis of Cohort Study.
    Zhang C; Wu J; Xu J; Xu J; Xian J; Xue S; Ye J
    Dis Markers; 2019; 2019():2046825. PubMed ID: 31814857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
    Alfaiate D; Clément S; Gomes D; Goossens N; Negro F
    J Hepatol; 2020 Sep; 73(3):533-539. PubMed ID: 32151618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review: chronic viral hepatitis and metabolic derangement.
    Wang CC; Cheng PN; Kao JH
    Aliment Pharmacol Ther; 2020 Jan; 51(2):216-230. PubMed ID: 31746482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis.
    Todowede OO; Mianda SZ; Sartorius B
    Syst Rev; 2019 Jan; 8(1):4. PubMed ID: 30606249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations.
    Wong GL; Chan HL; Yu Z; Chan AW; Choi PC; Chim AM; Chan HY; Tse CH; Wong VW
    Aliment Pharmacol Ther; 2014 Apr; 39(8):883-93. PubMed ID: 24612251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Syndrome and Clinical Outcomes of Patients with Gastric Cancer: A Meta-Analysis.
    Huang Z; Zhou J; Chen L; Zhang Y
    Horm Metab Res; 2023 May; 55(5):333-342. PubMed ID: 37011889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-dimensional shear wave elastography for significant liver fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis.
    Wei H; Jiang HY; Li M; Zhang T; Song B
    Eur J Radiol; 2020 Mar; 124():108839. PubMed ID: 31981878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis.
    Li Y; Zhao Y; Wu J
    PLoS One; 2017; 12(5):e0177713. PubMed ID: 28505202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Sarcopenia and Metabolic Syndrome in Middle-Aged and Older Non-Obese Adults: A Systematic Review and Meta-Analysis.
    Zhang H; Lin S; Gao T; Zhong F; Cai J; Sun Y; Ma A
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29547573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome and risk of ovarian cancer: a systematic review and meta-analysis.
    Chen Z; Liu Z; Yang H; Liu C; Kong F
    Front Endocrinol (Lausanne); 2023; 14():1219827. PubMed ID: 37693347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies.
    Hallajzadeh J; Khoramdad M; Izadi N; Karamzad N; Almasi-Hashiani A; Ayubi E; Qorbani M; Pakzad R; Hasanzadeh A; Sullman MJM; Safiri S
    Menopause; 2018 Oct; 25(10):1155-1164. PubMed ID: 29787477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between chronic hepatitis B infection and metabolic syndrome.
    Zhao X; Shah D; Sambamoorthi U
    J Diabetes Metab Disord; 2018 Dec; 17(2):223-232. PubMed ID: 30918858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance.
    Liu F; Wang XW; Chen L; Hu P; Ren H; Hu HD
    Aliment Pharmacol Ther; 2016 Jun; 43(12):1253-61. PubMed ID: 27117732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome and survival of patients with hepatocellular carcinoma: A meta-analysis.
    Fu J; Jiang J; Liu K
    Front Oncol; 2023; 13():1117846. PubMed ID: 36910647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between shift work and risk of metabolic syndrome: A systematic review and meta-analysis.
    Yang X; Di W; Zeng Y; Liu D; Han M; Qie R; Huang S; Zhao Y; Feng Y; Hu D; Sun L
    Nutr Metab Cardiovasc Dis; 2021 Sep; 31(10):2792-2799. PubMed ID: 34332862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
    Lu B; Qian JM; Li JN
    J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between shift work or long working hours with metabolic syndrome: a systematic review and dose-response meta-analysis of observational studies.
    Wang Y; Yu L; Gao Y; Jiang L; Yuan L; Wang P; Cao Y; Song X; Ge L; Ding G
    Chronobiol Int; 2021 Mar; 38(3):318-333. PubMed ID: 33557625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis.
    Campbell C; Wang T; McNaughton AL; Barnes E; Matthews PC
    J Viral Hepat; 2021 Mar; 28(3):493-507. PubMed ID: 33305479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies.
    Ding X; Zhao Y; Zhu CY; Wu LP; Wang Y; Peng ZY; Deji C; Zhao FY; Shi BY
    Endocr J; 2021 Sep; 68(9):1043-1056. PubMed ID: 33883332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review.
    Tseng CH; Tseng CM; Wu JL; Hsu YC; El-Serag HB
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1684-1693. PubMed ID: 32343431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.